- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Retinal Pigment Epithelial Detachment in United Kingdom
Total 1315 results
-
Roswell Park Cancer InstituteNovartisTerminatedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
Roswell Park Cancer InstituteCompletedStage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
National Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Stage II Renal Cell Cancer AJCC v7 | Stage I Renal Cell Cancer AJCC v6 and v7United States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Seagen Inc.Not yet recruitingRenal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedIntraocular Retinoblastoma | Recurrent Retinoblastoma | Extraocular RetinoblastomaUnited States, Canada, Puerto Rico
-
NewLink Genetics CorporationCompletedMetastatic Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Metastatic Kidney Cancer | Refractory Renal Cell Carcinoma | Metastatic Clear-cell Renal CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Renal Cell Carcinoma | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedRecurrent Renal Cell CancerUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States, Singapore, France, United Kingdom
-
Immatics Biotechnologies GmbHCompletedMetastatic Renal Cell CarcinomaUnited States, France, Romania, United Kingdom, Italy, Russian Federation, Poland, Germany, Hungary, Netherlands, Norway
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Unspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
Abramson Cancer Center at Penn MedicineMerck Sharp & Dohme LLCRecruitingRenal Cell CarcinomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminated
-
Oxford BioMedicaThe Methodist Hospital Research Institute; ORION Clinical ServicesCompletedCarcinoma, Renal CellUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Indiana UniversityTerminatedRenal Cell CarcinomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...WithdrawnRenal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterEli Lilly and CompanyTerminated
-
M.D. Anderson Cancer CenterTerminatedRenal Cell CancerUnited States
-
M.D. Anderson Cancer CenterEisai Inc.TerminatedRenal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
SCRI Development Innovations, LLCNovartisCompleted
-
Case Comprehensive Cancer CenterCompletedRenal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
Arkadiusz Z. Dudek, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompletedClear Cell Renal CarcinomaUnited States
-
Eisai Inc.CompletedKidney Neoplasms | Carcinoma, Renal Cell | Adenocarcinoma, Renal CellUnited States, France
-
IpsenCompletedLocally Advanced or Metastatic Renal Cell CarcinomaUnited States
-
Duke UniversityBayerTerminatedRenal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Metastatic Kidney CarcinomaUnited States
-
Peloton Therapeutics, Inc., a subsidiary of Merck...Active, not recruitingVHL - Von Hippel-Lindau Syndrome | VHL Gene Mutation | VHL Syndrome | VHL Gene Inactivation | VHL-Associated Renal Cell Carcinoma | VHL-Associated Clear Cell Renal Cell CarcinomaUnited States, Denmark, United Kingdom, France
-
Abramson Cancer Center of the University of PennsylvaniaUniversity of Pittsburgh; Rutgers Cancer Institute of New JerseyCompletedMetastatic Clear Cell Renal Cell CarcinomaUnited States
-
Mayo ClinicRecruitingClear Cell Renal Cell Carcinoma | Urothelial Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Kidney Oncocytoma | Clear Cell Papillary Renal TumorUnited States
-
Calithera Biosciences, IncCompletedMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States, United Kingdom, Australia, France, Italy, Germany, Spain, New Zealand
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Localized Transitional Cell Cancer of the...United States
-
Duke UniversityCompletedCarcinoma, Renal CellUnited States
-
University of Michigan Rogel Cancer CenterCompletedCarcinoma, Renal CellUnited States
-
Washington University School of MedicineCompleted
-
University of Kansas Medical CenterBayerCompletedRenal Cell CancerUnited States
-
Daniel George, MDNovartis; PfizerCompletedRenal Cell CarcinomaUnited States
-
National Center for Research Resources (NCRR)Duke UniversityUnknownRenal Cell CarcinomaUnited States
-
Argos TherapeuticsTerminatedRenal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaIsrael, Spain, United States, Czechia, Canada, Italy, Hungary, United Kingdom
-
PfizerActive, not recruiting
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedRenal Cell CarcinomaUnited States
-
PfizerCompleted
-
Indiana UniversityTerminatedRenal Cell CarcinomaUnited States
-
Oxford BioMedicaColumbia University; ORION Clinical ServicesCompletedA Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell CancerCarcinoma, Renal CellUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; AmgenTerminatedRenal Cell CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterNovartis; Pfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompletedRenal Cell CarcinomaUnited States
-
Chandru SundaramCompletedRenal Cell CarcinomaUnited States